Cost–benefit analysis of mammography screening: the perspective of Nigerian healthcare providers
Mammography screening is not cost-beneficial to the healthcare provider when clients are asked to pay OOP. This highlights the need to explore sustainable health financing mechanisms to support mammography screening in Nigeria.
Authors
- Ifeoma Umeh
- Ifeoma Jovita Nduka (ORCID: https://orcid.org/0000-0003-1487-4588)
- Sunday Odunke Nduka (ORCID: https://orcid.org/0000-0003-1963-5711)
- Obinna Ikechukwu Ekwunife (ORCID: https://orcid.org/0000-0003-0879-3861)
- Charles E. Okafor
- Daniel Orih
Institutions
- Nnamdi Azikiwe University (NG)
Publication Details
- Journal
- BMJ Public Health
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1136/bmjph-2024-001356
- Citations
- 1
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.28